SCHEMBL4860836

SCHEMBL4860836

CCC(CO)Nc1ccc(N)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.44
MAPT P10636 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CDK2 P24941 2/20 0.40
DYRK3 O43781 1/20 0.40
CCNT1 O60563 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
CDK5R1 Q15078 1/20 0.40
DYRK2 Q92630 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
RAD52 P43351 1/20 0.40
PDE10A Q9Y233 1/20 0.39
ALDH1A1 P00352 3/20 0.38
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3859936 0.92 SIGMAR1 (0.44) FYNMAPTCYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL3859541 0.90 MAPT (0.43) FYNMAPTCYP1A2CYP2C9CYP2C19
SCHEMBL4860025 0.88 TLR7 (0.40) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL4860226 0.85 TLR8 (0.44) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL4854316 0.84 CYP1A2 (0.39) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL14028554 0.81 TAS1R3 (0.41) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL4854597 0.80 SIGMAR1 (0.38) FYNMAPTCYP1A2CYP2C9CYP2C19
SCHEMBL4862775 0.80 SIGMAR1 (0.43) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL14941288 0.79 MAPT (0.42) MAPTCYP1A2CYP2C9CYP2C19SIGMAR1
SCHEMBL4862013 0.77 SIGMAR1 (0.41) FYNMAPTCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7445645-B2 Ortho-and/or meta-substituted N-alkylhydroxylated secondary para-phenylenediamine compounds, compositions for dyeing keratin fibers comprising such compounds, and processes of dyeing therewith L'OREAL S.A. (FR) 2008-11-04 US claimed
US-20060026774-A1 Ortho-and/or meta-substituted N-alkylhydroxylated secondary para-phenylenediamine compounds, compositions for dyeing keratin fibers comprising such compounds, and processes of dyeing therewith L'OREAL S.A. (FR) 2006-02-09 US claimed
EP-1568355-A1 N-alkylhydroxilated secondary paraphenylenediamine which is ortho- and/or meta substituted, composition for dying keratinous fibres comprising this paraphenylenediamine, methods based on this composition and uses. L'OREAL (FR) 2005-08-31 EP claimed
US-7445645-B2 Ortho-and/or meta-substituted N-alkylhydroxylated secondary para-phenylenediamine compounds, compositions for dyeing keratin fibers comprising such compounds, and processes of dyeing therewith L'OREAL S.A. (FR) 2008-11-04 US disclosed
US-7445645-B2 Ortho-and/or meta-substituted N-alkylhydroxylated secondary para-phenylenediamine compounds, compositions for dyeing keratin fibers comprising such compounds, and processes of dyeing therewith L'OREAL S.A. (FR) 2008-11-04 US disclosed
US-5158864-A COLOR PHOTOGRAPHIC MATERIAL AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1992-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060026774-A1 Ortho-and/or meta-substituted N-alkylhydroxylated secondary para-phenylenediamine compounds, compositions for dyeing keratin fibers comprising such compounds, and processes of dyeing therewith KRT18, CDC73, TYR FYN 516/4885MAPT 744/4885CYP1A2 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.